OTLK Outlook Therapeutics, Inc.

Fundamentals / CIK 0001649989 / USD

Outlook Therapeutics, Inc. reported $1.41M in revenue and a net loss of $61.12M for the fiscal year ended September 30, 2025, with a 4.0% gross margin and a -3935.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OTLK in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$15.99M$7.99M$0-$71.16MFY 2016 Revenue: $2.98MFY 2016 Net Income: -$53.30M2016FY 2017 Revenue: $3.81MFY 2017 Net Income: -$38.85M2017FY 2018 Revenue: $3.09MFY 2018 Net Income: -$30.09M2018FY 2019 Revenue: $8.15MFY 2019 Net Income: -$34.52M2019FY 2020 Net Income: -$35.24M2020FY 2021 Net Income: -$53.16M2021FY 2022 Net Income: -$66.05M2022FY 2023 Net Income: -$58.98M2023FY 2024 Net Income: -$75.37M2024FY 2025 Revenue: $1.41MFY 2025 Net Income: -$62.42M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue $1.41M -- -- -- -- -- $8.15M $3.09M $3.81M $2.98M
Cost of Revenue $1.36M -- -- -- -- -- -- -- -- --
Gross Profit $57K -- -- -- -- -- -- -- -- --
Research & Development $27.18M $41.76M $26.45M $42.33M $38.96M $26.34M $23.81M $18.50M $23.81M $32.76M
Selling, General & Admin $39.94M $29.94M -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- $51.73M $36.84M $44.45M $32.73M $39.69M $54.33M
Operating Income -$67.06M -$71.70M -$53.13M -$63.07M -$51.73M -$36.84M -$36.30M -$29.64M -$35.88M -$51.35M
EBITDA -$66.94M -$71.59M -$53.08M -$62.87M -$51.46M -$36.62M -$32.94M -$26.59M -$33.19M -$48.95M
Interest Income $90K $906K $971K -- -- -- -- -- -- --
Interest Expense -- $3.16M $2.53M -- -- $1.76M $3.47M $3.89M $5.63M $1.85M
Income Before Tax -$63.98M -$75.36M -$58.98M -$66.05M -$53.16M -$38.51M -$37.93M -$33.74M -$38.35M -$53.20M
Income Tax Expense -$1.55M $2.8K $2.8K $2.8K $2.0K -$3.27M -$3.41M -$3.65M $502K $103K
Net Income -$62.42M -$75.37M -$58.98M -$66.05M -$53.16M -$35.24M -$34.52M -$30.09M -$38.85M -$53.30M
Basic EPS -$1.79 -$4.06 -$4.72 -$6.20 -$7.00 -$13.40 -$39.60 -$195.20 -$267.20 -$587.20
Diluted EPS -$1.79 -$4.06 -$4.72 -$6.20 -$7.00 -$13.40 -$39.60 -$195.20 -$288.00 -$587.20
Basic Shares Outstanding 34.8M 18.5M 12.5M 10.6M 7.6M 3.6M 909.6K 246.6K 150.1K 107.6K
Diluted Shares Outstanding 34.8M 18.5M 12.5M 10.6M 7.6M 3.6M 909.6K 246.6K 150.3K 107.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue -- -- -- -- $1.51M -- -- --
Cost of Revenue $17K $149K $30K -- $440K -- -- --
Gross Profit -$8.3K -$22K -$1.24M -- $1.07M -- -- --
Research & Development $3.25M $4.50M $3.63M $5.98M $7.13M $4.41M $9.66M $12.52M
Selling, General & Admin $7.55M $9.50M $8.61M $10.33M $9.68M $7.98M $11.95M --
Operating Income -$10.81M -$14.03M -$13.48M -$17.31M -$15.75M -$12.39M -$21.61M -$22.88M
EBITDA -$10.80M -$14.00M -$13.45M -$17.28M -$15.72M -$12.36M -$21.58M -$22.85M
Income Before Tax -$20.32M -$4.45M -- -- -$20.15M -$46.35M -- --
Income Tax Expense -- -- -- -- -- $2.8K -- --
Net Income -$20.32M -$4.45M -$23.06M -$13.29M -$20.15M -$46.36M $17.38M $5.69M
Basic EPS -$0.15 -$0.05 -$0.38 -- -$0.55 -$1.50 $0.72 --
Diluted EPS -$0.15 -$0.05 -$0.38 -- -$0.55 -$1.50 $0.72 --
Basic Shares Outstanding 136.7M 81.8M 60.2M -- 37.0M 30.9M 24.2M --
Diluted Shares Outstanding 136.7M 81.8M 60.2M -- 37.0M 30.9M 24.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $8.08M $14.93M $23.39M $17.40M $14.48M $12.54M $8.02M $1.72M $3.19M $2.35M
Cash & Short-Term Investments $8.08M $14.93M $23.39M $17.40M $14.48M $12.54M $8.02M $1.72M $3.19M $2.35M
Accounts Receivable, Net $1.49M -- -- -- -- -- -- -- -- --
Inventory $3.34M -- -- -- -- -- -- -- -- --
Total Current Assets $17.39M $27.42M $30.98M $27.52M $21.51M $17.94M $13.50M $3.30M $3.90M $5.68M
Property, Plant & Equipment, Net -- -- -- -- $164K $327K $3.18M $18.49M $16.09M $18.66M
Other Non-Current Assets $418K $439K $501K $132K $175K $1.29M $457K $491K $740K $853K
Total Non-Current Assets $1.20M $1.41M $1.32M $1.01M $1.30M $1.79M $3.63M $18.98M $16.83M $19.73M
Total Assets $18.58M $28.82M $32.30M $28.53M $22.81M $19.73M $17.13M $22.28M $20.73M $25.41M
Accounts Payable $10.19M $7.97M $6.57M $3.49M $2.20M $2.39M $2.28M $3.61M $10.95M $5.07M
Short-Term Debt -- -- -- -- -- -- $1.03B $66K $53K $586K
Deferred Revenue (Current) -- -- -- -- -- -- -- $1.74M $3.09M $1.21M
Total Current Liabilities $45.81M $42.55M $46.73M $19.73M $6.75M $15.89M $20.29M $32.04M $28.74M $20.44M
Long-Term Debt -- -- -- -- -- -- $50.28M $98K $151K $2.23M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $2.76M $4.47M $5.15M
Other Non-Current Liabilities -- -- -- -- -- -- $3.94M $3.51M $2.57M $2.43M
Total Non-Current Liabilities $4.96M $59.35M $6.2K $61K $11.45M $1.02M $7.61M $11.05M $22.72M $10.14M
Total Liabilities $50.77M $101.9M $46.74M $19.79M $18.20M $16.91M $27.90M $43.09M $51.46M $30.58M
Total Debt (incl. Leases) $248K $298K $4.3K $43K $112K $260K $1.08B $165K $204K $2.82M
Common Stock $539K $239K $130K $2.27M $1.76M $1.27M $286K $90K $249K $228K
Retained Earnings -$605.7M -$543.3M -$467.9M -$408.9M -$342.9M -$289.7M -$254.5M -$216.3M -$186.2M -$147.4M
Total Stockholders' Equity -$32.19M -$73.08M -$14.44M $8.74M $4.61M $2.83M -$16.13M -$25.54M -$33.65M -$5.17M
Total Equity -$32.19M -$73.08M -$14.44M $8.74M $4.61M $2.83M -$16.13M -$25.54M -$33.65M -$5.20M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $11.24M $7.75M $8.68M $8.08M $8.90M $7.56M $5.70M $14.93M
Cash & Short-Term Investments $11.24M $7.75M $8.68M $8.08M $8.90M $7.56M $5.70M $14.93M
Accounts Receivable, Net $1.64M $2.72M $115K $1.49M $1.75M -- -- --
Inventory $5.04M $3.34M $3.46M $3.34M $4.13M $3.60M $3.11M --
Total Current Assets $23.17M $20.90M $17.17M $17.39M $21.10M $17.81M $15.67M $27.42M
Other Non-Current Assets $304K $320K $346K $418K $464K $394K $416K $439K
Total Non-Current Assets $3.02M $988K $1.07M $1.20M $1.30M $1.27M $1.34M $1.41M
Total Assets $26.18M $21.89M $18.24M $18.58M $22.39M $19.08M $17.01M $28.82M
Accounts Payable $6.81M $13.64M $7.32M $10.19M $10.26M $7.77M $12.19M $7.97M
Total Current Liabilities $28.68M $38.88M $49.06M $45.81M $31.49M $24.82M $48.24M $42.55M
Total Non-Current Liabilities $7.90M $12.00M $7.73M $4.96M $28.09M $26.72M $19.06M $59.35M
Total Liabilities $36.58M $50.89M $56.79M $50.77M $59.58M $51.54M $67.30M $101.9M
Total Debt (incl. Leases) $204K $219K $233K $248K $261K $273K $286K $298K
Common Stock $1.87M $1.05M $646K $539K $435K $329K $249K $239K
Retained Earnings -$653.5M -$633.2M -$628.8M -$605.7M -$592.4M -$572.3M -$525.9M -$543.3M
Total Stockholders' Equity -$10.39M -$28.99M -$38.55M -$32.19M -$37.19M -$32.46M -$50.29M -$73.08M
Total Equity -$10.39M -$28.99M -$38.55M -$32.19M -$37.19M -$32.46M -$50.29M -$73.08M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$62.42M -$75.37M -$58.98M -$66.05M -$53.16M -$35.24M -$34.52M -$30.09M -$38.85M -$53.33M
Depreciation & Amortization $117K $114K $44K $205K $262K $219K $3.36M $3.05M $2.69M $2.39M
Stock-Based Compensation $8.90M $5.39M $5.55M $7.71M $4.89M $2.81M $1.31M $1.99M $8.57M $12.45M
Change in Receivables -$1.49M -- -- -- -- -- -- -- -- $20K
Change in Inventory -$3.34M -- -- -- -- -- -- -- -- --
Change in Payables $1.67M $1.39M $3.08M $1.30M -$198K -$1.49M -$1.33M -$6.71M $5.73M -$5.33M
Operating Cash Flow -$51.83M -$68.79M -$42.97M -$56.67M -$54.25M -$31.79M -$32.29M -$33.04M -$15.51M -$45.48M
Capital Expenditure -- -- -- -- -- -- -$437K -$2.78M -$292K -$1.10M
Free Cash Flow -- -- -- -- -- -- -$32.73M -$35.82M -$15.80M -$46.58M
Investing Cash Flow -- -- -- -- -- -$900K -$437K -$2.78M -$292K -$1.10M
Common Stock Issued $25.40M $60.33M $30.02M $62.31M $46.30M $35.43M $45.96M $14.70M $1.61M $16.14M
Financing Cash Flow $44.98M $60.33M $48.97M $59.59M $56.19M $37.21M $39.03M $34.35M $16.63M $39.86M
Net Change in Cash -$6.84M -$8.46M $6.00M $2.92M $1.94M $4.52M $6.30M -$1.47M $834K -$6.72M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$20.32M -$4.45M -$23.06M -$13.29M -$20.15M -$46.36M $17.38M $5.69M
Depreciation & Amortization $14K $30K $30K $30K $29K $29K $29K $29K
Stock-Based Compensation $792K $757K $881K $1.82M $1.68M $1.72M $3.67M $1.41M
Change in Receivables $1.08M -$2.61M $1.38M -- -- -- -- --
Change in Inventory -$1.70M $114K -$120K $788K -$522K -$495K -$3.11M --
Change in Payables -$6.46M $5.71M -$2.87M $30K $2.04M -$4.63M $4.22M $2.53M
Operating Cash Flow -$21.01M -$7.83M -$14.94M -$12.38M -$11.90M -$16.58M -$10.97M -$16.98M
Common Stock Issued $25.20M $6.90M $14.93M $7.64M $14.60M $1.42M $1.74M --
Financing Cash Flow $26.60M $6.90M $15.53M $11.56M $13.25M $18.44M $1.74M -$115K
Net Change in Cash $3.49M -$929K $594K -$818K $1.34M $1.85M -$9.22M -$17.10M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Gross Margin 4.0% -- -- -- -- -- -- -- -- --
Operating Margin -4744.3% -- -- -- -- -- -445.6% -960.1% -941.4% -1723.3%
Net Profit Margin -4416.2% -- -- -- -- -- -423.8% -974.6% -1019.3% -1788.9%
Return on Equity (ROE) -- -- -- -756.0% -1153.9% -1246.8% -- -- -- --
Return on Assets (ROA) -335.9% -261.5% -182.6% -231.5% -233.1% -178.6% -201.5% -135.0% -187.4% -209.8%
Current Ratio 0.38x 0.64x 0.66x 1.39x 3.19x 1.13x 0.67x 0.10x 0.14x 0.28x
Quick Ratio 0.31x 0.35x 0.50x 0.88x 2.14x 0.79x 0.40x 0.05x 0.11x 0.12x
Debt to Equity -- -- -- 0.00x 0.02x 0.09x -- -- -- --
Revenue Growth (YoY) -- -- -- -- -- -- +163.8% -19.0% +27.9% -42.9%
10Y Revenue / Share Growth -100.0% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Assets (ROA) -233.4% -278.4% -564.0% -335.9% -194.0% 110.7% -275.3% -261.5%
Current Ratio 0.81x 0.54x 0.35x 0.38x 0.67x 0.72x 0.32x 0.64x
Quick Ratio 0.63x 0.45x 0.28x 0.31x 0.54x 0.57x 0.26x 0.35x
Gross Profit Growth (YoY) -100.8% -- -- -- -- -- -- --
Net Income Growth (YoY) -- -- -232.7% -333.6% -145.4% -- -- --
EPS Growth (YoY) -- -- -152.8% -- -128.8% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001649989) · from March 31, 2015 Data through June 30, 2026 · synced Nov 20, 2026, 05:48 UTC · Open in terminal